These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 35873891)

  • 21. National guidelines for diagnosis and treatment of malignant lymphoma 2022 in China (English version).
    Health Commission Of The People's Republic Of China N
    Chin J Cancer Res; 2022 Oct; 34(5):425-446. PubMed ID: 36398117
    [No Abstract]   [Full Text] [Related]  

  • 22. Comments on
    Feng Y; Wu N
    Chin J Cancer Res; 2022 Dec; 34(6):633-634. PubMed ID: 36714335
    [No Abstract]   [Full Text] [Related]  

  • 23. Comments on
    Zhang J; Si L; Guo J
    Chin J Cancer Res; 2022 Dec; 34(6):635-636. PubMed ID: 36714338
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis.
    Yamaguchi K; Okusaka T; Shimizu K; Furuse J; Ito Y; Hanada K; Shimosegawa T; Okazaki K;
    Pancreas; 2017; 46(5):595-604. PubMed ID: 28426492
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Guidelines for the diagnosis and treatment of pancreatic cancer in China(2021)].
    Chinese Pancreatic Surgery Association, Chinese Society of Surgery, Chinese Medical Association
    Zhonghua Wai Ke Za Zhi; 2021 Jul; 59(7):561-577. PubMed ID: 34256456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chinese guidelines for diagnosis and treatment of pancreatic cancer 2018 (English version).
    National Health Commission Of The People's Republic Of China
    Chin J Cancer Res; 2019 Apr; 31(2):278-294. PubMed ID: 31156299
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interpretation of the guidelines for neoadjuvant therapy of pancreatic cancer in China(2020 edition)].
    Qiu JD; Zhu RZ; Chen H; Zhang TP
    Zhonghua Wai Ke Za Zhi; 2021 Mar; 59(3):232-236. PubMed ID: 33685058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Systematic review of the methodology quality and reporting quality in colorectal cancer screening guidelines].
    Li J; Yao PT; Niu JQ; Sun X; Ren JS; Chen HD; Li X; Wei LP; Lyu ZY; Feng XS; Chen WQ; Li N; Dai M
    Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Apr; 53(4):398-404. PubMed ID: 30982275
    [No Abstract]   [Full Text] [Related]  

  • 29. [Expert consensus on the MDT model of pancreatic cancer in China (2020 Edition)].
    ; ;
    Zhonghua Zhong Liu Za Zhi; 2020 Jul; 42(7):531-536. PubMed ID: 32842438
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [China National Lung Cancer Screening Guideline with Low-dose Computed 
Tomography (2018 version)].
    Zhou Q; Fan Y; Wang Y; Qiao Y; Wang G; Huang Y; Wang X; Wu N; Zhang G; Zheng X; Bu H; Li Y; Wei S; Chen L; Hu C; Shi Y; Sun Y
    Zhongguo Fei Ai Za Zhi; 2018 Feb; 21(2):67-75. PubMed ID: 29526173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cultural adaptation of the mental health first aid guidelines for depression used in English-speaking countries for China: a Delphi expert consensus study.
    Lu S; Li W; Oldenburg B; Wang Y; Jorm AF; He Y; Reavley NJ
    BMC Psychiatry; 2020 Jun; 20(1):336. PubMed ID: 32586291
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional variations in mortality rates of pancreatic cancer in China: results from 1990-1992 national mortality survey.
    Chen KX; Wang PP; Zhang SW; Li LD; Lu FZ; Hao XS
    World J Gastroenterol; 2003 Nov; 9(11):2557-60. PubMed ID: 14606096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Critical appraisal of clinical practice guidelines for treating pancreatic cancer based on the global disease burden.
    Li CC; Wang YQ; Li YP; Li XL
    J Evid Based Med; 2015 Feb; 8(1):11-21. PubMed ID: 25594942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current diagnosis and treatment of pancreatic cancer in China.
    Guo X; Cui Z
    Pancreas; 2005 Jul; 31(1):13-22. PubMed ID: 15968242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is high-intensity focused ultrasound (HIFU) an option for neoadjuvant therapy for borderline resectable pancreatic cancer patients? - a systematic review.
    Stanislavova N; Karamanliev M; Ivanov T; Yotsov T; Zhou K; Dimitrov D
    Int J Hyperthermia; 2021 Sep; 38(2):75-80. PubMed ID: 34420446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Equivalence of Chinese and US-English versions of the SF-36 health survey.
    Yu J; Coons SJ; Draugalis JR; Ren XS; Hays RD
    Qual Life Res; 2003 Jun; 12(4):449-57. PubMed ID: 12797717
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Korean Surgical Practice Guideline for Pancreatic Cancer 2022: A summary of evidence-based surgical approaches.
    Lee SE; Han SS; Kang CM; Kwon W; Paik KY; Song KB; Yang JD; Chung JC; Jeong CY; Kim SW;
    Ann Hepatobiliary Pancreat Surg; 2022 Feb; 26(1):1-16. PubMed ID: 35220285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgeons' knowledge regarding the diagnosis and management of pancreatic cancer in China: a cross-sectional study.
    Li BQ; Wang L; Li J; Zhou L; Zhang TP; Guo JC; Zhao YP
    BMC Health Serv Res; 2017 Jun; 17(1):395. PubMed ID: 28599648
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systematic appraisal of guidelines for the diagnosis of pancreatic cancer.
    Liu XJ; Yang T; Shi X; Xiao BH; An LY; Zheng SY; Qi YX; Sun DL
    Gland Surg; 2021 Apr; 10(4):1487-1498. PubMed ID: 33968700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A study of implementation of national language policies in a local higher institution: a case study from China.
    Chen X
    Springerplus; 2016; 5(1):2060. PubMed ID: 27995037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.